Kim Sung-Wan, Kim Jae-Kyeong, Jhon Min, Kim Ju-Wan, Ryu Seunghyong, Lee Ju-Yeon, Kim Jae-Min
Department of Psychiatry, Chonnam National University Medical School, Gwangju, Republic of Korea.
Mindlink, Gwangju Bukgu Mental Health Center, Gwangju, Republic of Korea.
Digit Health. 2025 Jan 31;11:20552076251317556. doi: 10.1177/20552076251317556. eCollection 2025 Jan-Dec.
Despite increasing research on digital technologies for psychiatric disorders, studies specifically examining self-monitoring of symptoms with smartphone applications by patients with schizophrenia remain limited. This study aims to evaluate the validity and reliability of self-monitoring psychiatric symptoms using a smartphone application among patients with schizophrenia at Mindlink, a community-based early intervention center.
Fifty-three young patients with schizophrenia spectrum disorders participated. They rated their psychiatric symptoms across five domains-delusions, hallucinations, anxiety, depression, and perceived stress-using an 11-point Likert scale at baseline, 1 week, 8 weeks, and 16 weeks. Test-retest reliability was assessed using intraclass correlation coefficients (ICCs) between baseline and 1-week ratings. Concurrent validity was determined by correlating app-based ratings with established self-report and clinician-administered scales, including the Eppendorf Schizophrenia Inventory, Hamilton Program for Schizophrenia Voices Questionnaire, Beck Depression Inventory, Generalized Anxiety Disorder-7, and Perceived Stress Scale. The accuracy of the app's depression rating was assessed using receiver operating characteristic (ROC) analysis.
ICCs for test-retest reliability were high across all symptom domains, ranging from 0.741 to 0.876 ( < 0.001). Significant correlations were observed between app-based ratings and formal assessments at all time points. ROC analysis for single-item self-ratings using the app yielded an area under the curve of 0.829 ( = 0.002), indicating good accuracy.
This study demonstrates that self-monitoring of key symptoms and stress using a smartphone application is valid and reliable for patients with schizophrenia. These findings support the app's potential to enhance symptom management and enable early detection of relapse in this population.
尽管针对精神疾病的数字技术研究不断增加,但专门研究精神分裂症患者使用智能手机应用程序进行症状自我监测的研究仍然有限。本研究旨在评估在社区早期干预中心Mindlink,精神分裂症患者使用智能手机应用程序自我监测精神症状的有效性和可靠性。
五十三名患有精神分裂症谱系障碍的年轻患者参与了研究。他们在基线、1周、8周和16周时,使用11点李克特量表对五个领域的精神症状进行评分,这五个领域分别为妄想、幻觉、焦虑、抑郁和感知压力。通过组内相关系数(ICC)评估基线和1周评分之间的重测信度。通过将基于应用程序的评分与既定的自我报告量表和临床医生管理的量表进行关联来确定同时效度,这些量表包括埃彭多夫精神分裂症量表、汉密尔顿精神分裂症幻听问卷、贝克抑郁量表、广泛性焦虑障碍-7和感知压力量表。使用受试者工作特征(ROC)分析评估该应用程序抑郁评分的准确性。
所有症状领域的重测信度ICC都很高,范围从0.741到0.876(<0.001)。在所有时间点,基于应用程序的评分与正式评估之间均观察到显著相关性。使用该应用程序进行单项自我评分的ROC分析得出曲线下面积为0.829(=0.002),表明准确性良好。
本研究表明,对于精神分裂症患者,使用智能手机应用程序自我监测关键症状和压力是有效且可靠的。这些发现支持了该应用程序在改善该人群症状管理和实现复发早期检测方面的潜力。